Status:
COMPLETED
Renal Mass Registry
Lead Sponsor:
Mayo Clinic
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Collect valuable risk factor and quality of life data from Renal Cell Carcinoma patients and harness the latest technology to organize and analyze data.
Detailed Description
RCC is a cancer that is poorly understood. The increase in both incidence and mortality rates for RCC, coupled with the lack of effective therapies for RCC beyond surgical excision, underscore the nee...
Eligibility Criteria
Inclusion
- Inclusion:
- Patients with a renal mass or a suspected metastatic lesion from a renal primary who have been treated or are going to be studied and or treated surgically at Mayo Clinic Arizona
- Patients must be 18 years of age or older
- Patients must be capable of and willing to sign an informed consent
- Exclusion:
- None
Exclusion
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2017
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT01887574
Start Date
June 1 2013
End Date
April 12 2017
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259